Stock Earnings

Question 1

¿Cuáles son los estados financieros clave de Shanghai Pharmaceuticals Holding Co Ltd?

Accepted Answer

Según el último estado financiero (Form-10K), Shanghai Pharmaceuticals Holding Co Ltd tiene un total de activos de $221,209, una ganancia neta profit de $4,552

Question 2

¿Cuáles son los ratios financieros clave para SHPMF?

Accepted Answer

El ratio corriente de Shanghai Pharmaceuticals Holding Co Ltd es 1.47, el margen neto es 1.65, las ventas por acción son $74.31.

Question 3

¿Cómo se desglosan los ingresos de Shanghai Pharmaceuticals Holding Co Ltd por segmento o geografía?

Accepted Answer

Currently Shanghai Pharmaceuticals Holding Co Ltd data is not available.

Question 4

¿Es rentable Shanghai Pharmaceuticals Holding Co Ltd?

Accepted Answer

yes, según los últimos estados financieros, Shanghai Pharmaceuticals Holding Co Ltd tiene una ganancia neta profit de $4,552

Question 5

¿Tiene Shanghai Pharmaceuticals Holding Co Ltd alguna deuda?

Accepted Answer

yes, Shanghai Pharmaceuticals Holding Co Ltd tiene una deuda de 149,533

Question 6

¿Cuántas acciones en circulación tiene Shanghai Pharmaceuticals Holding Co Ltd?

Accepted Answer

Shanghai Pharmaceuticals Holding Co Ltd tiene un total de acciones en circulación de 3,707.97

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	280,694	275,250	260,295	231,981	215,824	191,909
Revenue Growth (YoY)	3%	6%	12%	7%	12%	3%
Cost of Revenue	251,639	244,758	229,276	201,503	187,332	164,871
Gross Profit	29,055	30,492	31,018	30,477	28,491	27,039
Selling, General & Admin	18,688	17,932	19,279	18,914	17,751	16,696
Research & Development	2,293	2,162	1,998	1,940	1,827	1,540
Operating Expenses	21,584	21,255	22,157	22,162	20,690	19,299
Other Non Operating Income (Expenses)	-134	-94	-600	-168	-53	26
Pretax Income	9,673	8,020	7,054	8,808	8,143	7,175
Income Tax Expense	2,840	2,149	1,887	1,816	1,869	1,570
Net Income	5,645	4,552	3,767	5,617	5,093	4,496
Net Income Growth	40%	21%	-33%	10%	13%	10%
Shares Outstanding (Diluted)	3,677.33	3,704.06	3,701.29	3,482.73	2,845.51	2,846
Shares Change (YoY)	-1%	0%	6%	22%	0%	0%
EPS (Diluted)	1.52	1.22	1.01	1.61	1.79	1.58
EPS Growth	40%	21%	-37%	-10%	13%	10%
Free Cash Flow	3,216	3,426	2,260	2,058	942	3,834
Free Cash Flow Per Share	0.87	0.92	0.61	0.59	0.33	1.34
Gross Margin	10.35%	11.07%	11.91%	13.13%	13.2%	14.08%
Operating Margin	2.66%	3.35%	3.4%	3.58%	3.61%	4.03%
Profit Margin	2.01%	1.65%	1.44%	2.42%	2.35%	2.34%
Free Cash Flow Margin	1.14%	1.24%	0.86%	0.88%	0.43%	1.99%
EBITDA	--	10,944	10,417	9,872	9,334	9,311
EBITDA Margin	--	3.97%	4%	4.25%	4.32%	4.85%
D&A For EBITDA	--	1,707	1,557	1,557	1,534	1,571
EBIT	7,471	9,237	8,860	8,315	7,800	7,740
EBIT Margin	2.66%	3.35%	3.4%	3.58%	3.61%	4.03%
Effective Tax Rate	29.36%	26.79%	26.75%	20.61%	22.95%	21.88%

Shanghai Pharmaceuticals Holding Co Ltd (SHPMF) Price

SHPMF Stock Price Chart

SHPMF Income

Follow-Up Questions